Get started
Author

Susanne Klein‐Scory

Observed names: Klein-Scory, Susanne, Klein-Scory, Susanne (Dr. rer. nat.), S. Klein-Scory, Susanne KLEIN, Susanne Klein, Susanne Klein-Scory, Susanne Klein-scory
ORCID: 0000-0003-1930-3354
Observed ORCID: 0000-0003-1930-3354
OpenAlex ID: A5049013255
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
2000 · Irmgard Schwarte-Waldhoff, Olga V. Volpert, et al. · Proceedings of the National Academy of Sciences · 266
MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL
2012 · Alexander Baraniskin, Karin Birkenkamp-Demtroder, et al. · Carcinogenesis · 162
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma
2012 · Alexander Baraniskin, Stefanie Nöpel‐Dünnebacke, et al. · International Journal of Cancer · 142
Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells
2011 · Kamila A. Adamczyk, Susanne Klein-Scory, et al. · Life Sciences · 106
Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer
2005 · Martin W. Volmer, Kai Stühler, et al. · PROTEOMICS · 88
DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression
1999 · Irmgard Schwarte-Waldhoff, Susanne Klein, et al. · Oncogene · 81
New insights in the composition of extracellular vesicles from pancreatic cancer cells: implications for biomarkers and functions
2014 · Susanne Klein-Scory, Mahnaz Moradian Tehrani, et al. · Proteome Science · 55
PDF
Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
2020 · Susanne Klein-Scory, Ingo Wahner, et al. · Frontiers in Oncology · 52
PDF
Soluble E‐cadherin as a serum biomarker candidate: Elevated levels in patients with late‐stage colorectal carcinoma and FAP
2010 · Jakob V. Weiß, Susanne Klein‐Scory, et al. · International Journal of Cancer · 44
PDF
Immunoscreening of the extracellular proteome of colorectal cancer cells
2010 · Susanne Klein-Scory, Salwa Kübler, et al. · BMC Cancer · 43
PDF
Tumor suppressor Smad4 mediates downregulation of the anti‐adhesive invasion‐promoting matricellular protein SPARC: Landscaping activity of Smad4 as revealed by a “secretome” analysis
2004 · Martin W. Volmer, Yvonne Radacz, et al. · PROTEOMICS · 43
Significance of Liquid Biopsy for Monitoring and Therapy Decision of Colorectal Cancer
2018 · Susanne Klein-Scory, Marina Maslova, et al. · Translational Oncology · 42
PDF
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells
2020 · Thomas Mika, Abdelouahid Maghnouj, et al. · Frontiers in Molecular Biosciences · 38
PDF
A Soluble Form of the Giant Cadherin Fat1 Is Released from Pancreatic Cancer Cells by ADAM10 Mediated Ectodomain Shedding
2014 · Nathalie Wojtalewicz, Elham Sadeqzadeh, et al. · PLoS ONE · 33
PDF
Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3ε
2011 · Sven-T Liffers, Abdelouahid Maghnouj, et al. · BMC Cancer · 33
PDF
Digital droplet PCR‐based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation
2019 · Thomas Mika, Alexander Baraniskin, et al. · International Journal of Laboratory Hematology · 30
A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery
2006 · Hanna C. Diehl, Kai Stühler, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 28
Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo
2009 · Michael Pohl, I. Stricker, et al. · Journal of Cancer Research and Clinical Oncology · 25
Role of cdc25-C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester
1996 · Holger Barth, Ingrid Hoffmann, et al. · Journal of Cellular Physiology · 24
Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
2020 · Thomas Mika, Swetlana Ladigan-Badura, et al. · Frontiers in Oncology · 22
PDF
Phase III FIRE-4 study (AIO KRK-0114): Influence of baseline liquid biopsy results in first-line treatment efficacy of FOLFIRI/cetuximab in patients with tissue RAS-WT mCRC.
2023 · Sebastian Stintzing, Volker Heinemann, et al. · Journal of Clinical Oncology · 21
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study
2025 · Sebastian Stintzing, Susanne Klein-Scory, et al. · Journal of Clinical Oncology · 20
Transcriptome-Wide Analysis of Human Liver Reveals Age-Related Differences in the Expression of Select Functional Gene Clusters and Evidence for a PPP1R10-Governed ‘Aging Cascade’
2021 · Thomas Schreiter, Robert K. Gieseler, et al. · Pharmaceutics · 16
PDF
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
2021 · Deepak Vangala, Swetlana Ladigan, et al. · Genome Medicine · 16
PDF
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer
2021 · Kelly E. Henry, Travis M. Shaffer, et al. · Journal of Nuclear Medicine · 14
PDF
Works count: 65
Citation count: 1,536
H-index: 21
I10-index: 31
Year
Topic
Type